Fish Oil and the Management of Hypertriglyceridemia
Authors:
- 1 January 2009
- journal article
- research article
- Published by SAGE Publications in Nutrition and Health
- Vol. 20 (1) , 41-49
Abstract
Hypertriglyceridemia, regarded as one of the independent clinical markers of metabolic syndrome, is a frequently observed disorder that has been shown to be common in the Arab region. Epidemiologic and clinical trials demonstrated that omega-3 fatty acids have the potential to reduce the incidence of cardiovascular disease (CVD); one of the mechanisms by which this effect is achieved is through reducing plasma triglyceride levels. There is strong scientific evidence from human trials that omega-3 fatty acids from either fish or fish oil supplements significantly reduce blood triglyceride levels and these benefits appear to be dose-dependent. The active ingredients of fish oils include the long chain fatty acids EPA and DHA. The ideal amount of omega-3 fatty acid that should be incorporated into the diet without provoking detrimental effects on other lipid components such as decreasing HDL-C and/or increasing LDL-C has not yet been elucidated. Presently, a prescription form of omega-3 fatty acid has been approved by the United States Food and Drug Administration (USFDA) as an adjunct to the diet for the treatment of very high triglyceride levels (~ 500 mg/dl) in adults. Patients with hypertriglyceridemia have been shown to respond well to the use of omega-3 fatty acids even when used in conjunction with statins where greater improvements in the lipid profile were found as compared to treatment with statins alone. A determinant of the responsiveness to fish oil could be attributed to the ApoE genotype of individuals.Keywords
This publication has 35 references indexed in Scilit:
- Fish Oil in Combination with High or Low Intakes of Linoleic Acid Lowers Plasma Triacylglycerols but Does Not Affect Other Cardiovascular Risk Markers in Healthy MenThe Journal of Nutrition, 2008
- Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish OilThe American Journal of the Medical Sciences, 2007
- Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- Prevalence of metabolic abnormalities in the Tunisian adults: a population based studyDiabetes & Metabolism, 2006
- Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjectsBritish Journal of Nutrition, 2004
- Prevalence of the Metabolic Syndrome Among Omani AdultsDiabetes Care, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemiaHeart, 2001
- Importance of n−3 fatty acids in health and diseaseThe American Journal of Clinical Nutrition, 2000
- Fish Oil Supplementation Versus Gemfibrozil Treatment in Hyperlipidemic NIDDMHormone and Metabolic Research, 1996